Acute Myeloid leukemia:
Patients are treated according to modified St. Jude AML 02 protocol9, we propose the following recommendations:
- Induction chemotherapy: Omit etoposide so induction consists of Ara-C
and Doxorubicin based on Medical research council AML 15 clinical
trial10.
- The use of G-CSF during induction chemotherapy 24 hours after
chemotherapy and 48 hours before the next cycle of chemotherapy if BMA
at D15 less than 5%.